Albumin-bilirubin score in non-malignant liver and other diseases  

作　　者：Li-Fan Zhang Liu-Xiang Chen Wen-Juan Yang Bing Hu 

机构地区：[1]Department of Gastroenterology and Hepatology,West China Hospital,Sichuan University,Chengdu 610041,Sichuan Province,China [2]Digestive Endoscopy Medical Engineering Research Laboratory,West China Hospital,Sichuan University,Chengdu 610041,Sichuan Province,China

出　　处：《World Journal of Gastroenterology》2024年第41期4481-4483,共3页世界胃肠病学杂志（英文）

基　　金：Supported by the Natural Science Foundation of Sichuan Province,China,No.2022NSFSC0819.

摘　　要：The albumin-bilirubin(ALBI)score is derived from albumin and bilirubin levels.Currently,the ALBI score is widely used in various clinical settings.A recent article in the World Journal of Gastroenterology summarized the application of the ALBI score in various non-malignant liver diseases.The ALBI score has a predictive power that is superior or non-inferior to established numerous measures.This may be related to its contiguity,sensitivity,and inclusion of albumin.While we recognize the good results of the ALBI score in a number of diseases,the ALBI score also has limitations.Variation studies for population characteristics and other factors should be performed to validate the performance of ALBI.Further modifications or optimization of ALBI scores should be taken into account.

关 键 词：Albumin-bilirubin score Liver cirrhosis HEPATITIS Liver transplantation Liver injury 

分 类 号：R575[医药卫生—消化系统]